Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-22-042262

Chief Executive Officer gave up 5,219 shares (to pay taxes)

  • Chief Executive Officer acquired 1,504 shares (other)
  • Chief Executive Officer acquired 19,768 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Quart Barry D Chief Executive Officer 2022-04-29 Other acquisition +1,504 $3.84 $5,778 132,688 D
Quart Barry D Chief Executive Officer 2022-07-13 Option exercise +3,646 136,334 D
Quart Barry D Chief Executive Officer 2022-07-13 Option exercise +16,122 152,456 D
Quart Barry D Chief Executive Officer 2022-07-13 Shares withheld for taxes −5,219 $3.01 $15,709 147,237 D
Derivatives
Quart Barry D Chief Executive Officer 2022-07-13 Option exercise · Restricted Stock Units −3,646 32,812 D
Quart Barry D Chief Executive Officer 2022-07-13 Option exercise · Restricted Stock Units −16,122 147,051 D
Loading xslF345X03/doc4.xml…